London Medical Laboratory’s tests show 80% of children may develop allergies if parents have them

The study is the UK’s most comprehensive allergy test, analysing 295 allergens, including well known potential food allergens

Read on PharmaTimes

PrecisionLife and Sano Genetics partnership will help identify treatments for long COVID

The project will analyse risks from Sano Genetics’ data from 3,000 UK adults suffering from long COVID

Read on PharmaTimes

New data reinforces AstraZeneca and Sanofi’s nirsevimab as effective RSV immunisation

Nirsevimab is the first investigational immunisation designed to protect all infants across the RSV season with a single dose

Read on PharmaTimes

First treatment option indicated for CKD in Scotland for 20 years

NICE recommendation for Forxiga could entitle 53,000 adults to the new kidney disease therapy

Read on PharmaTimes

University of Aberdeen study finds diabetes almost doubles risk of COVID-19 death

Researchers reviewed findings from 158 global studies to determine how COVID-19 affects people living with diabetes

Read on PharmaTimes

1 2 3

Top of page

Industry News

Sarclisa is a monoclonal antibody which targets a specific epitope on the CD38 receptor on multiple myeloma cells.
Read More >

More Stories

News

Recent launch of several new categories of compound which include the spirocyclic β-Lactams designed...
Read More >

More Stories

Latest Tweets

Follow Us